NexPoint, a multibillion-dollar alternative investment firm, is seeking to raise $31 million for its newly launched NexPoint Life Sciences III DST, reinforcing the firm’s commitment to life sciences real estate.
NexPoint also said the Delaware Statutory Trust (DST) acquired a 138,000-square-foot life sciences industrial manufacturing property in Woodbury, Minn., within the Minneapolis/St. Paul/Bloomington Metropolitan Statistical Area (the MSA). The MSA is a hub for research and development in the medical technology field, which is enhanced by the concentration of high-powered academic and medical institutions.
The Woodbury property serves as the global headquarters and a research, formulation and development facility for Kindeva Drug Delivery, a contract development and manufacturing organization (CDMO) that develops and manufactures products across a range of complex drug-delivery formats. The property offers clinical manufacturing space, development laboratory spa